Mr. Zeeshan Saeed reports

FSD PHARMA PROVIDES UPDATE FROM CELLY NU'S PARTNERSHIP WITH SIX+ONE FOR UNBUZZD(TM)

FSD Pharma Inc. has provided an update by way of a news release issued by Celly Nutrition Corp., and its launching of unbuzzd, an innovative beverage product that is scientifically formulated from a proprietary blend of vitamins, minerals and botanical extracts, designed to support the body's natural processes for metabolizing alcohol and promoting alertness.

On April 25, 2024, Celly Nu announced a strategic partnership with Six+One, a purpose-driven branding, advertising and production agency based in New York, as follows below.

Celly Nutrition is thrilled to unveil its groundbreaking partnership with Six+One, a visionary move designed to significantly enhance the presence of its premier dietary supplement, unbuzzd, in preparation of the launch in the United States. This strategic alliance is more than just a collaboration, it's a bold step forward, leveraging Six+One's unparalleled branding and strategic expertise to redefine wellness. Renowned for its innovative work with brands like vitaminwater and Body Armor (both brands later acquired by The Coca-Cola Company), Six+One brings a disruptive approach to the marketplace, emphasizing the importance of marketing a brand's purpose beyond its product. This ethos, which aligns perfectly with today's consumer desire to understand the why behind a brand, sets the stage for a transformative journey for unbuzzd, promising to connect with audiences on a deeper, more meaningful level.

Through this collaboration, Six+One has been retained to undertake a comprehensive brand development for unbuzzd, encompassing: establishing a brand personality, visual identity creation, packaging design and building the company website.

John Duffy, chief executive officer of Celly Nutrition, expressed his enthusiasm for the partnership, stating: "Working with Eric Rojas and the Six+One team not only aligns with our strategic vision but also showcases an innovative approach that could potentially amplify unbuzzd's market impact. Their proven track record, especially in facilitating notable brand acquisitions, speaks volumes about their capability to deliver beyond expectations."

Mr. Rojas, founder of Six+One, shared his excitement about the collaboration, emphasizing the unique appeal of the unbuzzd brand: "The people behind unbuzzd are dream clients. They are redefining their category -- and fully understand that disruptive, zeitgeisty branding is the only way to get on the public's radar. Together, we're going to make unbuzzd a household name and improve a lot of wedding speeches."

unbuzzd is a scientifically formulated blend of vitamins, minerals and herbs engineered to expedite alcohol metabolism, facilitate faster recovery from alcohol consumption, and simultaneously enhance mental alertness to those individuals who consume it.

The coming launch of unbuzzd is being driven by the executive guidance of beverage industry luminaries like Gerry David, the former chief executive officer at Celsius Holdings Inc., where he helped build the foundation to what is today one of the most successful beverages over the past decade. In addition Mr. Duffy, a seasoned executive with an extensive background at Coca-Cola Enterprises and The Coca-Cola Company, is leading the charge as CEO. They are supported by Kevin Harrington (known as the inventor of the infomercial, the original shark on Shark Tank, and the As Seen on TV pioneer).

About FSD Pharma Inc.

FSD Pharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc., FSD Pharma is focused on the research and development of its lead compound, Lucid-MS (formerly Lucid-21-302). Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma has also licensed unbuzzd, a proprietary formulation of natural ingredients, vitamins and minerals to help with liver and brain function for the purposes of quickly relieving individuals from the effects of alcohol consumption for use in the consumer recreational sector, to Celly Nutrition Corp. and is entitled to a royalty on the revenue generated by Celly Nu from sales of products created using the technology rights granted under the licensing agreement. FSD Pharma continues its research and development activities to develop novel formulations for alcohol misuse disorders, and continues the development of such treatments for use in the health care sector. FSD Pharma maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represent loans secured by residential or commercial property.

We seek Safe Harbor.